Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease



Rating:

Share or cite this content

Citations should be made in the following way:
F. Polverino, C. Santoriello, F. Andò, C. De Rosa, L. Politi, G. Girbino, M. Polverino, J. Milic-Emili (Cava dei Tirreni, Messina, Florence, Italy; Montreal, Canada). Recumbent deoxygenation ("clinodeoxia") is a main feature of the mild/moderate liver cirrhosis. Eur Respir J 2009; 34: Suppl. 53, 1732

Member's Comments

No comment yet.

Related content which might interest you: Chronic kidney disease (CKD) – A forgotten co-morbidity in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Pulmonary arterial hypertension (PAH) among end state renal disease (ESRD) patients under chronic hemodyalisis (HD) Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007 Impact of borderline (BL) pulmonary hypertension (PH) in chronic lung diseases (CLD). Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Late Breaking Abstract: Pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF) in early course of disease – A prospective evaluation with right heart catheterization (RHC) in the ARTEMIS-IPF study Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Hedgehog-interacting protein (HHIP) polymorphisms and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Neutrophilic reversible airways dysfunction (NRAD) after liver transplantation: a case report Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 Assessment of dyspnoea in patients with liver cirrhosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Ventilatory and metabolic adaptations to cycling (C) and walking (W) in patients with chronic heart failure (CHF) Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001 The indices of body composition (IBC) consideration the changes of serum TNF-α, hormones and oxygen saturation (SO2%) in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Pulmonary hypertension (PH) in end-stage renal (ESRD) patients receiving dialysis: prevalence and clinical significance Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007 The relationship between echodensitometric parameters of respiratory muscles (RM) and indices of body composition (IBC) in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - Various issues in clinical physiology Year: 2012 Role of tadalafil in patients with hypoxia / lung disease induced (group 3) pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 Evolution of gas exchange abnormalities in patients with liver cirrhosis candidate for liver transplantation Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010